Form 4 for PRLB Proto Labs Inc
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001437749-22-003678 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-15 | PRLB | Klaas Bjoern | VP, Mng Dir-PL Europe | A - Grant | $0.00 | +3,788 | 12.5K | +43% | $0 |
| DM | 2022-02-17 | 2022-02-15 | PRLB | Klaas Bjoern | VP, Mng Dir-PL Europe | A - Grant | $0.00 | +5,936 | 1,894 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | A | A | 3,788 | $0.00 | 12,544 | D | — | — | (F1) Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-02-15 | A | A | 4,042 | $0.00 | 4,042 | D | $59.40 · — to 2032-02-13 | 4,042 Common Stock | (F2) 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. |
| 3 | Derivative | Performance Stock Units | 2022-02-15 | A | A | 1,894 | $0.00 | 1,894 | D | — · — to 2024-12-31 | 1,894 Common Stock | (F3) Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. |